Metabolic studies in an unusual case of asymptomatic familial hypobetalipoproteinemia with hypolphalipoproteinemia and fasting chylomicronemia
- PMID: 221546
- PMCID: PMC372117
- DOI: 10.1172/JCI109451
Metabolic studies in an unusual case of asymptomatic familial hypobetalipoproteinemia with hypolphalipoproteinemia and fasting chylomicronemia
Abstract
A new kindred with asymptomatic hypobetalipoproteinemia is reported. The proband, age 67, differs from previously described cases in several respects: (a) unusually low levels of low density lipoprotein (LDL) cholesterol (4-8 mg/dl); (b) normal triglyceride levels; (c) low levels of high density lipoprotein; (d) mild fat malabsorption; and (e) a defect in chylomicron clearance. On a high-carbohydrate diet his plasma triglyceride levels, instead of rising, actually fell. Turnover of triglycerides in very low density lipoproteins (VLDL) was low (2.8 mg/kg per h). Fractional catabolic rate of LDL protein was just above the normal range (0.655/d) but net turnover was <10% of normal (0.65 mg/kg per d). The half-life of his chylomicrons was 29 min, five times the normal value. Postheparin lipoprotein lipase activity was normal and apolipoprotein C-II, the activator protein for lipoprotein lipase, was present and functional. Apolipoprotein C-III(1), however, was not detected in the VLDL fraction, a finding previously reported in patients with abetalipoproteinemia. Fecal excretion of cholesterol was almost twice normal; total sterol balance was increased by congruent with40%. The unusual features in the proband that distinguish him from previously described cases and from his affected first-degree relatives suggested that, in addition to the basic gene defect affecting LDL metabolism, he might have a second abnormality affecting clearance of chylomicrons and VLDL. The ratio of apolipoprotein E(3) to E(2) in his VLDL fraction was 0.93, just below the lower limit of normal, suggesting heterozygosity for E(3) deficiency. Whether or not this contributes to his hypertriglyceridemia remains to be established.
Similar articles
-
Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients.J Clin Invest. 1986 Feb;77(2):520-7. doi: 10.1172/JCI112332. J Clin Invest. 1986. PMID: 3944267 Free PMC article.
-
Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.Artery. 1982;10(4):266-85. Artery. 1982. PMID: 7181672
-
Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.Arterioscler Thromb Vasc Biol. 2004 Sep;24(9):1703-7. doi: 10.1161/01.ATV.0000137975.14996.df. Epub 2004 Jul 8. Arterioscler Thromb Vasc Biol. 2004. PMID: 15242863
-
Pathogenesis and management of lipoprotein disorders.N Engl J Med. 1985 May 16;312(20):1300-10. doi: 10.1056/NEJM198505163122007. N Engl J Med. 1985. PMID: 3887163 Review. No abstract available.
-
The plasma lipoproteins: structure and metabolism.Annu Rev Biochem. 1978;47:751-7. doi: 10.1146/annurev.bi.47.070178.003535. Annu Rev Biochem. 1978. PMID: 209732 Review. No abstract available.
Cited by
-
Hepatocyte nuclear factor 1 and C/EBP are essential for the activity of the human apolipoprotein B gene second-intron enhancer.Mol Cell Biol. 1992 Mar;12(3):1134-48. doi: 10.1128/mcb.12.3.1134-1148.1992. Mol Cell Biol. 1992. PMID: 1545795 Free PMC article.
-
Apolipoprotein B-100 deficiency. Intestinal steatosis despite apolipoprotein B-48 synthesis.J Clin Invest. 1985 Aug;76(2):403-12. doi: 10.1172/JCI111986. J Clin Invest. 1985. PMID: 4031057 Free PMC article.
-
Familial hypobetalipoproteinemia-induced nonalcoholic steatohepatitis.Case Rep Gastroenterol. 2012 May;6(2):429-37. doi: 10.1159/000339761. Epub 2012 Jul 3. Case Rep Gastroenterol. 2012. PMID: 22855658 Free PMC article.
-
The rationale for initiating treatment of hypercholesterolemia in young adulthood.Curr Atheroscler Rep. 2013 Jan;15(1):296. doi: 10.1007/s11883-012-0296-2. Curr Atheroscler Rep. 2013. PMID: 23232986 Review.
-
Genetic analysis of a kindred with familial hypobetalipoproteinemia. Evidence for two separate gene defects: one associated with an abnormal apolipoprotein B species, apolipoprotein B-37; and a second associated with low plasma concentrations of apolipoprotein B-100.J Clin Invest. 1987 Jun;79(6):1842-51. doi: 10.1172/JCI113026. J Clin Invest. 1987. PMID: 3473077 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources